MEDIA

EVENTS

On November 29-30 in Warsaw the Gianni Benzi Foundation and the Children’s Memorial Health Institute (IPCZD) are organizing the SMART Final Open workshop "Paediatric Foresight Training Course: Current status and future changes in the European paediatric biomedical research”.

The workshop is aimed at evaluating the competences gained by the Children’s Memorial Health Institute staff and the general results of SMART project.The meeting also foresees the participation of interested stakeholders including young scientists to be involved in future research, government representatives, regulatory bodies, industry, trainees and voluntary associations.

The following topics will be addressed:

  • Paediatric biomedical research – novelties in the regulatory, academic and ethical framework
  • The paediatric initiatives around Europe
  • How to prepare and run paediatric clinical trials
  • Paediatric research innovative
  • Paediatric Formulations

SMART is the EU H2020 project aimed at raising the IPCZD staff’s research profile and increase capacity in providing innovative paediatric research methods such as PK-PD data Modelling&Simulation (M&S) data extrapolation, and suitable dosage forms identification. To improve the level of high-quality paediatric research in Poland, it was proposed a composite training programme addressing staff from IPCZD and including lessons (e-learning and face-to-face), staff exchanges and summer schools.
Three internationally-leading research institutions, CVBF in Italy, UCL in the United Kingdom and AMU in France contributed to the training program by providing specific expertise in paediatric clinical trial government and developing, M&S and Extrapolation applications, new formulation generation. All these institutions have a solid experience and previous participation in large paediatric research Networks and Consortia. IPCZD is a large tertiary paediatric hospital, having a strong interest in paediatric research.
As IPCZD staff has enhanced its know-how on paediatric trials and drug development, the institution is expected to be candidate to assume a leading role in the paediatric research European framework, and to become even more attractive for private-public collaborations.

Pin It on Pinterest

Share This